NCT06294821View on ClinicalTrials.gov

4AP to Delay Carpal Tunnel Release (CTR)

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

November 30, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

July 31, 2028

Conditions
Compression NeuropathyCarpal Tunnel Syndrome
Interventions
DRUG

4-Aminopyridine

Subjects will receive either the active study drug (4-aminopyridine) or placebo to determine the effects of 4AP on carpal tunnel syndrome

OTHER

Placebo

Subjects will receive either the active study drug (4-aminopyridine) or placebo to determine the effects of 4AP on carpal tunnel syndrome

All Listed Sponsors
lead

John Elfar

OTHER